Telix Pharmaceuticals Ltd
TLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002007191
No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.
Other share classesTLPPF
13F holders, Q2 2025
Institutional positions in Telix Pharmaceuticals Ltd as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +15 vs. Q1 2025
- Shares held
- 452.5K
- +404.8K (+849.6%) vs. Q1 2025
- Total value
- $7.29M
- +$6.49M (+812.3%) vs. Q1 2025
- New holders
- 16
- 3 more added
- Sold out
- 1
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $36.6M |
| Q1 2026 | 40 | $24.5M |
| Q4 2025 | 40 | $8.47M |
| Q3 2025 | 27 | $7.88M |
| Q2 2025 | 21 | $7.29M |
| Q1 2025 | 6 | $798.6K |
| Q4 2024 | 1 | $57.4K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Telix Pharmaceuticals Ltd; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pier Capital, LLC | 188,992 | $3.04M | 0.46% | +188,992 | New |
| Russell Investments Group, Ltd. | 60,301 | $975.1K | 0.00% | +60,301 | New |
| FMR LLC | 42,091 | $680.6K | 0.00% | +42,091 | New |
| Citadel Advisors LLC | 41,328 | $668.3K | 0.00% | +41,328 | New |
| Jane Street Group, LLC | 35,103 | $564.1K | 0.00% | +35,103 | New |
| Private Advisor Group, LLC | 25,167 | $404.4K | 0.00% | +15,027+148.2% | Added |
| JustInvest LLC | 18,475 | $296.9K | 0.00% | +18,475 | New |
| Blair William & Co | 13,500 | $216.9K | 0.00% | +13,500 | New |
| IHT Wealth Management, LLC | 13,240 | $212.8K | 0.01% | +13,240 | New |
| UBS Group AG | 6,121 | $98.4K | 0.00% | +2,470+67.7% | Added |
| Morgan Stanley | 4,402 | $70.7K | 0.00% | −1,232−21.9% | Reduced |
| Raymond James Financial Inc | 1,200 | $19.3K | 0.00% | +1,200 | New |
| Rhumbline Advisers | 1,187 | $19.2K | 0.00% | +41+3.6% | Added |
| SRS Capital Advisors, Inc. | 1,030 | $16.6K | 0.00% | +1,030 | New |
| Royal Bank of Canada | 141 | $2.00K | 0.00% | +141 | New |
| EverSource Wealth Advisors, LLC | 67 | $1.08K | 0.00% | −70−51.1% | Reduced |
| Advisor Group Holdings, Inc. | 45 | $723 | 0.00% | +45 | New |
| JFS Wealth Advisors, LLC | 27 | $434 | 0.00% | +27 | New |
| Principal Securities, Inc. | 21 | $337 | 0.00% | +21 | New |
| Assetmark, Inc | 18 | $289 | 0.00% | +18 | New |
| True Wealth Design, LLC | 10 | $161 | 0.00% | +10 | New |
| Abc Arbitrage SA | 0 | $0 | 0.00% | −26,939−100.0% | Sold out |